Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 67296-2289

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 67296-2289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A cumulative incidence graph comparing Placebo and Rosuva over 5 years. The y-axis shows cumulative incidence percentage. The graph includes hazard ratio (HR 0.56) with 95% confidence interval (0.46-0.69) and significance (P<0.001). The lower number at risk for both groups is displayed over time.*

FDA Label Image

Figure2 (Image 01)

A data table presenting the number of events for various endpoints comparing Rosuvastatin Calcium 20 mg and placebo at 20 mg. The table includes event rates, hazard ratios with 95% confidence intervals, and P values for cardiovascular outcomes such as primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), hospitalized unstable angina, and arterial revascularization. A hazard ratio forest plot is shown on the right.*

FDA Label Image

Figure3 (Image 02)

A box plot chart showing the percent change from baseline in LDL-C (low-density lipoprotein cholesterol) across doses of four statins: Rosuvastatin (10, 20, 40 mg), Atorvastatin (10, 20, 40, 80 mg), Simvastatin (10, 20, 40, 80 mg), and Pravastatin (10, 20, 40 mg). The vertical axis represents percent change, with reductions ranging approximately from 0 to -75%. The chart compares LDL-C lowering effects among these statins at various doses.*

FDA Label Image

Lbl10mg90s (Lbl10mg90s)

Label for Rosuvastatin Tablets USP 10 mg, film-coated tablets in a package of 90 tablets. The label includes dosage information, warnings, storage conditions, and manufacturing details. Manufactured by Glenmark Pharmaceuticals Ltd and marketed by Northstar Rx LLC.*

FDA Label Image

Lbl20mg90s (Lbl20mg90s)

Label for Rosuvastatin Tablets USP 20 mg film-coated tablets, packaged in a container of 90 tablets. The label states the product is manufactured by Glenmark Pharmaceuticals Ltd. in India for Northstar Rx LLC, Memphis, TN. Storage instructions and a barcode are also visible, with a prominent blue highlight on the 20 mg strength.*

FDA Label Image

Lbl40mg30s (Lbl40mg30s)

Label for Rosuvastatin Tablets USP, 40 mg, film-coated oral tablets. The package contains 30 tablets. Label includes manufacturer information for Northstar Rx LLC in Memphis, TN, and Glenmark Pharmaceuticals Ltd. in India. Storage instructions note to keep tablets between 20°C to 25°C and protect from moisture. The label displays an NDC number, barcode, and is marked Rx only.*

FDA Label Image

Lbl5mg90s (Lbl5mg90s)

Packaging label of Rosuvastatin Tablets USP, 5 mg strength, film-coated tablets. The label indicates a quantity of 90 tablets. It includes storage instructions, warnings, and manufacturer details: Glenmark Pharmaceuticals Ltd., India, and Northstar Rx LLC, Memphis, TN. The label features a barcode and the NorthStar logo.*

FDA Label Image

Structure (Structure)

Chemical structure of Rosuvastatin Calcium, showing its molecular framework including fluorophenyl, sulfonamide, and hydroxy acid groups as well as calcium ions binding two molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.